Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBurford Capital Regulatory News (BUR)

Share Price Information for Burford Capital (BUR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,135.00
Bid: 0.00
Ask: 1,320.00
Change: 0.00 (0.00%)
Spread: 188.00 (16.608%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,135.00
BUR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on Management, Governance & Related Matters

7 Jan 2020 07:00

RNS Number : 9162Y
Burford Capital Limited
07 January 2020
 

 

 

7 January 2020

 

UPDATE ON MANAGEMENT, CORPORATE GOVERNANCE AND RELATED MATTERS

 

Burford Capital Limited ("Burford Capital" or "Burford" or "the Company"), the leading global finance and investment management firm focused on law, today provides the following update on a variety of management, corporate governance and related matters.

 

Management structure

 

Burford believes it has the deepest management bench in the industry and has announced the following management changes to ensure that it is positioned for future global growth as the business enters its second decade.

 

·; Aviva Will and David Perla will become Burford's Co-Chief Operating Officers. They will be jointly responsible for Burford's global marketing, origination and underwriting activities, along with the management of the teams engaged in those activities across all our offices.

·; Craig Arnott will become Burford's Deputy Chief Investment Officer, working with CIO Jonathan Molot across our entire investment portfolio, and will also retain responsibility for growing and developing the Australian market.

·; Mark Klein, Burford's General Counsel, will add the role of Chief Administrative Officer, managing our legal, operational and administrative functions.

 

Burford will continue to be managed by its Management Committee, composed of Christopher Bogart (Chief Executive Officer), Jonathan Molot (Chief Investment Officer), Jim Kilman (Chief Financial Officer), Elizabeth O'Connell (Chief Strategy Officer) and the four executives named above.

 

US securities litigation against Burford

 

Burford is pleased to report that the US securities class action against Burford filed in August 2019 has been withdrawn by the plaintiffs and dismissed in its entirety. There is no litigation pending against Burford at present other than ordinary course skirmishing within a small number of ongoing funded investment matters.

 

Burford's Board of Directors

 

As previously announced, David Lowe will leave the Board at the May 2020 AGM, and Sir Peter Middleton will leave the Board at the May 2021 AGM. The Company has engaged Korn Ferry to lead a search for two new independent Board directors. That search has been proceeding well and the interview process around new directors is ongoing. We expect to be in a position to nominate two new directors (at least one of whom will be qualified for audit committee membership) for shareholder consideration as part of the Board elections to be held at the May 2020 AGM.

 

The Board also intends to nominate Christopher Bogart, Burford's CEO, to join the Board; that nomination will also be put to shareholder election as part of the May 2020 AGM. In response to shareholder inquiries, Burford confirms that it intends to keep the roles of Chairman and CEO separate.

 

Listing arrangements

 

As previously announced, Burford plans either to add a US listing on the New York Stock Exchange or NASDAQ for trading in its ordinary shares or to migrate to the London Stock Exchange ("LSE") Main Market.

 

Burford and its lawyers have completed extensive preparatory and analytical work with respect to a potential US listing under the Securities Act of 1933, and Burford is now ready to undertake the formal process of seeking a US listing, which is commenced by submitting a registration statement to the US Securities and Exchange Commission ("SEC"). Burford will be seeking a full-fledged US listing of its ordinary shares as opposed to an American Depository Receipt ("ADR") structure; once effective, Burford's ordinary shares would trade on both the US exchange and LSE AIM. Burford does not intend to issue new equity as part of the US listing.

 

Burford is eligible to list in the US as a "foreign private issuer", a listing status that permits Burford to continue to report its accounts under International Financial Reporting Standards ("IFRS") and not move to US Generally Accepted Accounting Principles ("GAAP") and quarterly reporting. (This is the same status used by firms such as Barclays and Fiat Chrysler.) Although Burford does not need to produce US GAAP financial statements in order to file its registration statement with the SEC, it does need to provide IFRS statements that are prepared and audited pursuant to applicable SEC rules for foreign private issuers, including the auditing standards established by the US Public Company Accounting Oversight Board ("PCAOB"), as opposed to statements prepared and audited pursuant to International Accounting Standards ("IAS") which are required by the LSE. Ernst & Young LLP, Burford's auditors, are planning to be able to provide the necessary PCAOB audit opinions for the years ended 31 December 2017, 2018 and 2019 as part of our filing with the SEC after the release of Burford's 2019 results, with the expectation that Burford's registration statement would be filed with the SEC in April 2020. It is not viable to file a registration statement without including Burford's 2019 results.

 

The ultimate timing for any listing is difficult to predict and will depend on a variety of factors, including the SEC comment process. Burford is constrained by applicable law from commenting in any detail on its progress towards adding a US listing and thus Burford will not be able to update the market further with the ongoing details of the listing process.

 

Management compensation

 

In response to shareholder inquiries, Burford confirms that it will provide in its 2019 annual report information about management compensation (including individual compensation disclosure for Messrs Bogart and Molot) consistent with the disclosure obligations to which it will be subject under its potential US listing even though those obligations will not yet have taken effect.

 

Financial calendar

 

Burford presently intends to release its full year results for the year ended 31 December 2019 on Tuesday 24 March 2020 and will host a management call for analysts and investors that day at 2:00pm Greenwich Mean Time / 10:00am Eastern Time; further details will be provided in due course.

 

Burford's Annual General Meeting will be held on Wednesday 13 May 2020 at 2:30pm British Summer Time.

 

LTIP-related share purchase

 

Burford intends to purchase as soon as practical up to 410,000 of its ordinary shares for total value not to exceed £4 million. These shares will be purchased for use in satisfying any vested share awards made under the Company's 2016 Long Term Incentive Plan ("LTIP").

 

 

For further information, please contact:

 

Burford Capital Limited

Jim Kilman, Chief Financial Officer

+1 917 985 9840

Robert Bailhache, Head of Investor Relations - email

 

+44 (0)20 3530 2023

Macquarie Capital (Europe) Limited - NOMAD and Joint Broker

+44 (0)20 3037 2000

Jonny Allison

Alex Reynolds

Jefferies International Limited - Joint Broker

+44 (0)20 7029 8000

Graham Davidson

Tony White

Numis Securities Limited - Joint Broker

+44 (0)20 7260 1000

Charlie Farquhar

Jonathan Abbott

 

About Burford Capital

Burford Capital is the leading global finance and investment management firm focused on law. Its businesses include litigation finance and risk management, asset recovery and a wide range of legal finance and advisory activities. Burford is publicly traded on the London Stock Exchange, and it works with law firms and clients around the world from its principal offices in New York, London, Chicago, Washington, Singapore and Sydney.

 

For more information about Burford: www.burfordcapital.com

 

 

This release does not constitute an offer of any Burford fund.  Burford Capital Investment Management LLC ("BCIM"), which acts as the fund manager of all Burford funds, is registered as an investment adviser with the U.S. Securities and Exchange Commission. The information provided herein is for informational purposes only. Past performance is not indicative of future results. The information contained herein is not, and should not be construed as, an offer to sell or the solicitation of an offer to buy any securities (including, without limitation, interests or shares in the funds). Any such offer or solicitation may be made only by means of a final confidential Private Placement Memorandum and other offering documents.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDEAAFKEDLEEAA
Date   Source Headline
7th Jul 202312:45 pmRNSPricing of Early Redemption of 2024 Bonds
4th Jul 20235:00 pmRNSTransaction in Own Shares
3rd Jul 20232:00 pmRNSCompletion of Share Purchases & PDMR Transactions
29th Jun 202311:14 amRNSIntended Purchases of Ordinary Shares
26th Jun 20236:00 pmRNSDirector/PDMR Shareholding
26th Jun 20232:08 pmRNSUpdate & Release Date for 2Q23 Results
26th Jun 20232:07 pmRNSNotice of Early Redemption of Bonds due 2024
26th Jun 20232:05 pmRNSClosing of Private Offering of Senior Notes
23rd Jun 20237:00 amRNSPricing of Senior Notes Offering
22nd Jun 20235:22 pmRNSDirector/PDMR Shareholding
20th Jun 20231:00 pmRNSPrivate Offering of Senior Notes
13th Jun 202312:00 pmRNS1Q23 Results & Quarterly Report
8th Jun 20233:00 pmRNSNotice of 1Q23 Results & Results Call Details
6th Jun 202312:00 pmRNSNotice of Retail Shareholder Call on June 21, 2023
6th Jun 202312:00 pmRNSNotice of 2023 AGM
2nd Jun 202312:00 pmRNSSterling FX Rate for Second 2022 Interim Dividend
16th May 202312:00 pmRNSAvailability of 2022 Annual Report
16th May 202312:00 pmRNSAnnual results for year ended December 31, 2022
3rd May 20237:00 amRNSNotice of 2022 Results and Update on Accounting
3rd Apr 20237:30 amRNSRestoration - Burford Capital Limited
3rd Apr 20237:00 amRNSStatement on YPF Summary Judgment Ruling
31st Mar 20234:57 pmRNSSuspension - Burford Capital Limited
31st Mar 20234:14 pmRNSStatement re Petersen and Eton Park Matters
29th Mar 20233:00 pmRNSTransaction in Own Shares
22nd Mar 20234:00 pmRNSDirector/PDMR Shareholding
16th Mar 20237:00 amRNSUpdate on 2022 Business Activity
3rd Jan 202312:00 pmRNSUpdate on and Completion of Share Purchases by EBT
30th Dec 20221:13 pmRNSDirector/PDMR Shareholding
28th Dec 202212:00 pmRNSUpdate on Share Purchases by EBT
16th Dec 202212:00 pmRNSUpdate on Share Purchases by EBT
9th Dec 20225:00 pmRNSDirector/PDMR Shareholding
9th Dec 20227:00 amRNSIntended Share Purchases by Employee Benefit Trust
25th Nov 202212:00 pmRNSDirector/PDMR Bondholding
16th Nov 202212:00 pmRNSAppointment of Joint Corporate Broker
9th Nov 202212:00 pmRNSSterling FX Rate for 2022 Interim Dividend
1st Nov 20221:23 pmRNSBurford Capital Releases 2022 GC Survey Results
13th Sep 20223:27 pmRNSBurford Capital-Report on Class Action Recoveries
6th Sep 20227:00 amRNSJordan Licht Appointed Chief Financial Officer
26th Aug 20222:00 pmRNSDirector/PDMR Shareholding
24th Aug 20222:00 pmRNSDirector/PDMR Shareholding
16th Aug 20222:00 pmRNSPDMR Shareholding and Transaction in Own Shares
9th Aug 202212:01 pmRNSDr. Rukia Baruti Appointed as Board Director
9th Aug 202212:00 pmRNSInterim Results for six months ended 30 June 2022
26th Jul 20222:00 pmRNSTR-1: Notification of Major Holdings
26th Jul 202212:00 pmRNSNotice of 1H22 Results Date & Results Call Details
25th Jul 20222:00 pmRNSTR-1: Notification of Major Holdings
27th Jun 202211:30 amRNSDirector/PDMR Shareholding
15th Jun 20225:30 pmRNSPurchases of Shares for NED Plan and PDMR Notices
13th Jun 20227:00 amRNS$350 Million Post-Settlement Investment Fund Close
10th Jun 20223:00 pmRNSIntended Purchases of Ordinary Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.